Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ENVISION

Financiado

Cerrado

Intelligent plug and play digital tool for real time surveillance of COVID 19 pa...

Intelligent plug and play digital tool for real time surveillance of COVID 19 patients and smart decision making in Intensive Care Units Within only six months, over 7.4 million people have been diagnosed with SARS-CoV-2. In the most severely hit countries, more than 10% of infected patients have received treatment in Intensive Care Units (ICUs). Insufficient data... ver más

31/07/2023

GUF

6M€

Presupuesto del proyecto: 6M€

Líder del proyecto

JOHANN WOLFGANG GOETHEUNIVERSITAET FRANKFURT... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 23 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2023-07-31

SC1-PHE-CORONAVIRUS-2020-2B: Medical technologies, Digital tools...

I+D

Cerrada hace 4 años

0% 86% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

23 Participantes

GUF

1.06M€ | Lider

SEMMELWEIS UNIVERSITY

90.00K€ | Participante

WEST UNIVERSITY OF TIMISOARA

90.00K€ | Participante

UKCL

102.50K€ | Participante

Proyectos interesantes

COVend

Medical Technol...

Data Science

10M€ Cerrado

ECMO-BIOMARKER

Medical Technol...

Data Science

4M€ Cerrado

TED2021-131536B-I00

Medical Technol...

Data Science

142K€ Cerrado

COVIRNA

Medical Technol...

Data Science

4M€ Cerrado

TIQUE

Medical Technol...

Data Science

6M€ Cerrado

CoronAI

Medical Technol...

Artificial Inte...

3M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 33 meses Fecha Inicio: 2020-10-13
Fecha Fin: 2023-07-31

Líder del proyecto

JOHANN WOLFGANG GOETHEUNIVERSITAET FRANKFURT... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 6M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Within only six months, over 7.4 million people have been diagnosed with SARS-CoV-2. In the most severely hit countries, more than 10% of infected patients have received treatment in Intensive Care Units (ICUs). Insufficient data and limited knowledge on the disease as well as the lack of tools to support the intensivist in making accurate, timely and informed decisions has led to high mortality rates. Continuous surveillance, the collection and intelligent analysis of data from many sources, including ventilators and electrical impedance tomography, would allow intensivists to decide on the best suitable treatment to accelerate the recovery of the often comorbid COVID-19 patients, while reducing the burden on clinical staff and healthcare costs. This information would also increase our understanding of the yet unknown course of disease, supporting other stakeholders in the quest for new therapies. In ENVISION, our multidsciplinary public-private consortium will advance an innovative digital tool, Sandman.MD, a real-time and plug-and-play monitoring app, to an intelligent decision-support system for monitoring, prediction and treatment of COVID-19 patients in ICUs – the Sandman.ICU – reaching Technology Readiness Level 9 and ready for CE marking by the end of the project. The app has been developed by our SME partner app@work and successfully introduced by several hospitals in Germany for use during the perioperative period. Sandman.ICU will be integrated into an AI-driven data analytics suite with predictive modelling tools and enhanced with a smart alert functionality. The digital tool will be validated and demonstrated in 14 hospitals across Europe. Our Health Technology Assessment expert partner will demonstrate the economic and societal value of Sandman.ICU, while an experienced SME will manage the innovation process in view of an immediate market uptake. The rollout will be supported by the European Society of Anaesthesiology and Intensive Care.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores